Germline cancer risk alleles in CHEK2 and ATM, as well as in CTC1 (a gene associated with telomere maintenance and DNA replication), were identified as risk factors for the development of CH via rare variant gene burden testing (Kessler et al., 2022). The gene discussed is CHEK2; the disease is cyclic hematopoiesis.